HEADER ANTIBIOTIC 30-APR-10 2XDC TITLE STRUCTURE OF LINEAR GRAMICIDIN D OBTAINED USING TYPE I CRYSTALS GROWN TITLE 2 IN A LIPID CUBIC PHASE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: GRAMICIDIN A; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: VALYL GRAMICIDIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BREVIBACILLUS BREVIS; SOURCE 3 ORGANISM_TAXID: 1393; SOURCE 4 ATCC: 8246 KEYWDS ANTIBIOTIC, ION CHANNEL, MONOOLEIN, LIPID CUBIC PHASE, MESOPHASE KEYWDS 2 SPONGE PHASE, BILAYER, ANTIFUNGAL, ANTIBACTERIAL EXPDTA X-RAY DIFFRACTION AUTHOR N.HOEFER,D.ARAGAO,M.CAFFREY REVDAT 9 16-OCT-24 2XDC 1 REMARK REVDAT 8 07-FEB-24 2XDC 1 REMARK REVDAT 7 15-NOV-23 2XDC 1 LINK ATOM REVDAT 6 29-MAR-23 2XDC 1 AUTHOR REMARK LINK REVDAT 5 06-MAR-19 2XDC 1 REMARK LINK REVDAT 4 29-AUG-12 2XDC 1 REVDAT JRNL REMARK REVDAT 3 13-JUL-11 2XDC 1 VERSN REVDAT 2 12-JAN-11 2XDC 1 JRNL REMARK REVDAT 1 11-AUG-10 2XDC 0 JRNL AUTH N.HOEFER,D.ARAGAO,M.CAFFREY JRNL TITL CRYSTALLIZING TRANSMEMBRANE PEPTIDES IN LIPIDIC MESOPHASES JRNL REF BIOPHYS.J. V. 99 23 2010 JRNL REFN ISSN 0006-3495 JRNL PMID 20682243 JRNL DOI 10.1016/J.BPJ.2010.05.011 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.15 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 3 NUMBER OF REFLECTIONS : 11147 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 604 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 690 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.45 REMARK 3 BIN R VALUE (WORKING SET) : 0.2050 REMARK 3 BIN FREE R VALUE SET COUNT : 29 REMARK 3 BIN FREE R VALUE : 0.2220 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 816 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 105 REMARK 3 SOLVENT ATOMS : 2 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02000 REMARK 3 B22 (A**2) : -0.04000 REMARK 3 B33 (A**2) : 0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.112 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.108 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.059 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.796 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.950 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 972 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1292 ; 1.622 ; 1.936 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 86 ; 5.506 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 24 ;34.016 ;20.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 38 ; 8.825 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 136 ; 0.149 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 584 ; 0.015 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 484 ; 1.755 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 736 ; 2.921 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 488 ; 3.613 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 554 ; 5.377 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2XDC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-APR-10. REMARK 100 THE DEPOSITION ID IS D_1290042607. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03312 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL CRYO-COOLED REMARK 200 OPTICS : SI(111) DOUBLE CRYSTAL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11779 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 31.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.26000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1AL4 REMARK 200 REMARK 200 REMARK: DATA WERE COLLECTED USING A COLLIMATED MINIBEAM WITH A 10 REMARK 200 MICRON BEAMSIZE. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 %(W/V) POLYETHYLENE GLYCOL (PEG) REMARK 280 6000, 0.1 M BICINE, PH 9.0. LIPIDIC CUBIC PHASE OF MONOOLEIN WAS REMARK 280 USED IN A RATIO OF 1:20 (MOL/MOL) GRAMICIDIN D TO MONOOLEIN REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.28000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 4080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 3020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 3110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 GRAMICIDIN IS A HETEROGENEOUS MIXTURE OF SEVERAL COMPOUNDS REMARK 400 INCLUDING GRAMICIDIN A, B AND C WHICH ARE OBTAINED FROM REMARK 400 BACILLUS BREVIS AND COLLECTIVELY CALLED GRAMICIDIN D REMARK 400 HERE, GRAMICIDIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: GRAMICIDIN A REMARK 400 CHAIN: A, B, C ,D, E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 16 REMARK 400 DESCRIPTION: GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE REMARK 400 WITH ALTERNATING D,L CHARACTERISTICS. REMARK 400 THE N-TERM VALINE IS FORMYLATED (RESIDUE 1). REMARK 400 THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). REMARK 400 REMARK 400 THE GRAMICIDIN A IS POLYPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: GRAMICIDIN A REMARK 400 CHAIN: A, B, C, D, E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH REMARK 400 ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS REMARK 400 FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH REMARK 400 ETHANOLAMINE (RESIDUE 16). REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ETA D 16 C - N - CA ANGL. DEV. = -15.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 9 113.52 -161.67 REMARK 500 TRP A 13 93.44 -160.05 REMARK 500 TRP A 15 92.09 -166.14 REMARK 500 TRP B 15 96.78 -164.53 REMARK 500 TRP C 9 111.08 -160.66 REMARK 500 TRP C 11 95.63 -162.30 REMARK 500 TRP C 15 84.83 -164.37 REMARK 500 TRP D 13 84.66 -151.83 REMARK 500 TRP E 9 109.42 -163.86 REMARK 500 TRP E 11 97.67 -160.11 REMARK 500 TRP E 15 85.89 -166.80 REMARK 500 TRP F 13 87.40 -152.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TRP D 15 ETA D 16 -148.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 TRP D 15 -12.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 15P A 1017 REMARK 610 15P B 1016 REMARK 610 15P C 1016 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A1018 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 15P A1016 O5 REMARK 620 2 15P A1016 O6 51.7 REMARK 620 3 15P A1016 O7 99.2 55.2 REMARK 620 4 15P A1017 O1 130.8 172.9 118.5 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 15P A 1016 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 15P A 1017 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 1018 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 15P B 1016 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 15P C 1016 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF GRAMICIDIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF GRAMICIDIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF GRAMICIDIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF GRAMICIDIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF GRAMICIDIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF GRAMICIDIN A REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TK2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN S COMPLEXED WITH ALKALINE REMARK 900 PROTEINASE SAVINASE REMARK 900 RELATED ID: 2XDC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN A FROM CRYSTALS GROWN IN A LIPID REMARK 900 CUBIC PHASE. REMARK 900 RELATED ID: 1AV2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN A COMPLEXED WITH CESIUM CHLORIDE REMARK 900 RELATED ID: 1BDW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN A FROM BACILLUS BREVIS REMARK 900 RELATED ID: 1C4D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN A COMPLEXED WITH CESIUM CHLORIDE REMARK 900 RELATED ID: 1GMK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN A COMPLRXED WITH POTASSIUM REMARK 900 THIOCYANATE REMARK 900 RELATED ID: 1GRM RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE GRAMICIDIN A REMARK 900 RELATED ID: 1JNO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A IN SODIUM DODECYL SULFATE REMARK 900 MICELLES REMARK 900 RELATED ID: 1KQE RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF A LINKED SHORTENED GRAMICIDIN A IN BENZENE/ REMARK 900 ACETONE 10:1 REMARK 900 RELATED ID: 1MAG RELATED DB: PDB REMARK 900 SOLID STATE NMR STRUCTURE OF GRAMICIDIN A IN HYDRATED DMPC BILAYERS, REMARK 900 RELATED ID: 1MIC RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A IN METHANOL IN THE PRESENCE OF REMARK 900 CACL REMARK 900 RELATED ID: 1NG8 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A (W15G) IN SODIUM DODECYL SULFATE REMARK 900 MICELLES REMARK 900 RELATED ID: 1NRM RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A IN DODECYL PHOSPHOCHOLINE REMARK 900 MICELLES REMARK 900 RELATED ID: 1NRU RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A IN DODECYL PHOSPHOCHOLINE REMARK 900 MICELLES IN THE PRESENCE OF EXCESS NA+ REMARK 900 RELATED ID: 1NT5 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A (V1F) IN SODIUM DODECYL SULFATE REMARK 900 MICELLES REMARK 900 RELATED ID: 1JO3 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN B IN SODIUM DODECYL SULFATE REMARK 900 MICELLES REMARK 900 RELATED ID: 1JO4 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN C IN SODIUM DODECYL SULFATE REMARK 900 MICELLES REMARK 900 RELATED ID: 1NT6 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF F1-GRAMICIDIN C IN SODIUM DODECYL SULFATE REMARK 900 MICELLES REMARK 900 RELATED ID: 1TKQ RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF A LINKED UNSYMMETRIC GRAMICIDIN A IN A REMARK 900 MEMBRANE-ISOELECTRICAL SOLVENTS MIXTURE, IN THE PRESENCE OF CSCL REMARK 900 RELATED ID: 1W5U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN D IN ETHANOL REMARK 900 RELATED ID: 2IZQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN D COMPLEX WITH KI IN METHANOL REMARK 900 RELATED ID: 3L8L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN D COMPLEX WITH NAI REMARK 900 RELATED ID: 1AL4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN D IN N-PROPANOL REMARK 900 RELATED ID: 1ALX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN D IN METHANOL REMARK 900 RELATED ID: 1ALZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN D IN ETHANOL DBREF 2XDC A 1 16 NOR NOR00243 NOR00243 1 16 DBREF 2XDC B 1 16 NOR NOR00243 NOR00243 1 16 DBREF 2XDC C 1 16 NOR NOR00243 NOR00243 1 16 DBREF 2XDC D 1 16 NOR NOR00243 NOR00243 1 16 DBREF 2XDC E 1 16 NOR NOR00243 NOR00243 1 16 DBREF 2XDC F 1 16 NOR NOR00243 NOR00243 1 16 SEQRES 1 A 16 FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TRP DLE TRP SEQRES 2 A 16 DLE TRP ETA SEQRES 1 B 16 FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TRP DLE TRP SEQRES 2 B 16 DLE TRP ETA SEQRES 1 C 16 FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TRP DLE TRP SEQRES 2 C 16 DLE TRP ETA SEQRES 1 D 16 FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TRP DLE TRP SEQRES 2 D 16 DLE TRP ETA SEQRES 1 E 16 FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TRP DLE TRP SEQRES 2 E 16 DLE TRP ETA SEQRES 1 F 16 FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TRP DLE TRP SEQRES 2 F 16 DLE TRP ETA MODRES 2XDC FVA A 1 VAL N-FORMYL-L-VALINE MODRES 2XDC FVA B 1 VAL N-FORMYL-L-VALINE MODRES 2XDC FVA C 1 VAL N-FORMYL-L-VALINE MODRES 2XDC FVA D 1 VAL N-FORMYL-L-VALINE MODRES 2XDC FVA E 1 VAL N-FORMYL-L-VALINE MODRES 2XDC FVA F 1 VAL N-FORMYL-L-VALINE HET FVA A 1 13 HET DLE A 4 8 HET DVA A 6 7 HET DVA A 8 7 HET DLE A 10 8 HET DLE A 12 8 HET DLE A 14 8 HET ETA A 16 4 HET FVA B 1 13 HET DLE B 4 8 HET DVA B 6 7 HET DVA B 8 7 HET DLE B 10 8 HET DLE B 12 8 HET DLE B 14 8 HET ETA B 16 4 HET FVA C 1 9 HET DLE C 4 8 HET DVA C 6 7 HET DVA C 8 7 HET DLE C 10 8 HET DLE C 12 8 HET DLE C 14 8 HET ETA C 16 4 HET FVA D 1 9 HET DLE D 4 8 HET DVA D 6 7 HET DVA D 8 7 HET DLE D 10 8 HET DLE D 12 8 HET DLE D 14 8 HET ETA D 16 8 HET FVA E 1 9 HET DLE E 4 8 HET DVA E 6 7 HET DVA E 8 7 HET DLE E 10 8 HET DLE E 12 8 HET DLE E 14 8 HET ETA E 16 4 HET FVA F 1 9 HET DLE F 4 8 HET DVA F 6 7 HET DVA F 8 7 HET DLE F 10 8 HET DLE F 12 8 HET DLE F 14 8 HET ETA F 16 4 HET 15P A1016 22 HET 15P A1017 22 HET NA A1018 1 HET 15P B1016 49 HET 15P C1016 11 HETNAM FVA N-FORMYL-L-VALINE HETNAM DLE D-LEUCINE HETNAM DVA D-VALINE HETNAM ETA ETHANOLAMINE HETNAM 15P POLYETHYLENE GLYCOL (N=34) HETNAM NA SODIUM ION HETSYN 15P PEG 1500 FORMUL 1 FVA 6(C6 H11 N O3) FORMUL 1 DLE 24(C6 H13 N O2) FORMUL 1 DVA 12(C5 H11 N O2) FORMUL 1 ETA 6(C2 H7 N O) FORMUL 7 15P 4(C69 H140 O35) FORMUL 9 NA NA 1+ FORMUL 12 HOH *2(H2 O) SHEET 1 AA 2 GLY A 2 DLE A 14 0 SHEET 2 AA 2 GLY B 2 DLE B 14 -1 O ALA B 3 N TRP A 13 SHEET 1 CA 2 ALA C 3 DLE C 14 0 SHEET 2 CA 2 GLY D 2 DLE D 14 -1 O ALA D 3 N TRP C 13 SHEET 1 EA 2 ALA E 3 DLE E 14 0 SHEET 2 EA 2 GLY F 2 DLE F 14 -1 O ALA F 3 N TRP E 13 LINK C FVA A 1 N GLY A 2 1555 1555 1.33 LINK C ALA A 3 N DLE A 4 1555 1555 1.32 LINK C DLE A 4 N ALA A 5 1555 1555 1.33 LINK C ALA A 5 N DVA A 6 1555 1555 1.32 LINK C DVA A 6 N VAL A 7 1555 1555 1.33 LINK C VAL A 7 N DVA A 8 1555 1555 1.32 LINK C DVA A 8 N TRP A 9 1555 1555 1.33 LINK C TRP A 9 N DLE A 10 1555 1555 1.31 LINK C DLE A 10 N TRP A 11 1555 1555 1.33 LINK C TRP A 11 N DLE A 12 1555 1555 1.33 LINK C DLE A 12 N TRP A 13 1555 1555 1.34 LINK C TRP A 13 N DLE A 14 1555 1555 1.35 LINK C DLE A 14 N TRP A 15 1555 1555 1.32 LINK C TRP A 15 N ETA A 16 1555 1555 1.31 LINK C FVA B 1 N GLY B 2 1555 1555 1.33 LINK C ALA B 3 N DLE B 4 1555 1555 1.33 LINK C DLE B 4 N ALA B 5 1555 1555 1.33 LINK C ALA B 5 N DVA B 6 1555 1555 1.33 LINK C DVA B 6 N VAL B 7 1555 1555 1.34 LINK C VAL B 7 N DVA B 8 1555 1555 1.32 LINK C DVA B 8 N TRP B 9 1555 1555 1.32 LINK C TRP B 9 N DLE B 10 1555 1555 1.34 LINK C DLE B 10 N TRP B 11 1555 1555 1.35 LINK C TRP B 11 N DLE B 12 1555 1555 1.31 LINK C DLE B 12 N TRP B 13 1555 1555 1.34 LINK C TRP B 13 N DLE B 14 1555 1555 1.34 LINK C DLE B 14 N TRP B 15 1555 1555 1.33 LINK C TRP B 15 N ETA B 16 1555 1555 1.31 LINK C FVA C 1 N GLY C 2 1555 1555 1.33 LINK C ALA C 3 N DLE C 4 1555 1555 1.32 LINK C DLE C 4 N ALA C 5 1555 1555 1.34 LINK C ALA C 5 N DVA C 6 1555 1555 1.33 LINK C DVA C 6 N VAL C 7 1555 1555 1.35 LINK C VAL C 7 N DVA C 8 1555 1555 1.33 LINK C DVA C 8 N TRP C 9 1555 1555 1.32 LINK C TRP C 9 N DLE C 10 1555 1555 1.33 LINK C DLE C 10 N TRP C 11 1555 1555 1.34 LINK C TRP C 11 N DLE C 12 1555 1555 1.33 LINK C DLE C 12 N TRP C 13 1555 1555 1.32 LINK C TRP C 13 N DLE C 14 1555 1555 1.35 LINK C DLE C 14 N TRP C 15 1555 1555 1.32 LINK C TRP C 15 N ETA C 16 1555 1555 1.33 LINK C FVA D 1 N GLY D 2 1555 1555 1.32 LINK C ALA D 3 N DLE D 4 1555 1555 1.33 LINK C DLE D 4 N ALA D 5 1555 1555 1.34 LINK C ALA D 5 N DVA D 6 1555 1555 1.33 LINK C DVA D 6 N VAL D 7 1555 1555 1.33 LINK C VAL D 7 N DVA D 8 1555 1555 1.33 LINK C DVA D 8 N TRP D 9 1555 1555 1.33 LINK C TRP D 9 N DLE D 10 1555 1555 1.32 LINK C DLE D 10 N TRP D 11 1555 1555 1.33 LINK C TRP D 11 N DLE D 12 1555 1555 1.35 LINK C DLE D 12 N TRP D 13 1555 1555 1.33 LINK C TRP D 13 N DLE D 14 1555 1555 1.33 LINK C DLE D 14 N TRP D 15 1555 1555 1.33 LINK C TRP D 15 N AETA D 16 1555 1555 1.34 LINK C TRP D 15 N BETA D 16 1555 1555 1.33 LINK C FVA E 1 N GLY E 2 1555 1555 1.32 LINK C ALA E 3 N DLE E 4 1555 1555 1.33 LINK C DLE E 4 N ALA E 5 1555 1555 1.34 LINK C ALA E 5 N DVA E 6 1555 1555 1.33 LINK C DVA E 6 N VAL E 7 1555 1555 1.34 LINK C VAL E 7 N DVA E 8 1555 1555 1.33 LINK C DVA E 8 N TRP E 9 1555 1555 1.33 LINK C TRP E 9 N DLE E 10 1555 1555 1.31 LINK C DLE E 10 N TRP E 11 1555 1555 1.34 LINK C TRP E 11 N DLE E 12 1555 1555 1.33 LINK C DLE E 12 N TRP E 13 1555 1555 1.32 LINK C TRP E 13 N DLE E 14 1555 1555 1.35 LINK C DLE E 14 N TRP E 15 1555 1555 1.31 LINK C TRP E 15 N ETA E 16 1555 1555 1.32 LINK C FVA F 1 N GLY F 2 1555 1555 1.34 LINK C ALA F 3 N DLE F 4 1555 1555 1.33 LINK C DLE F 4 N ALA F 5 1555 1555 1.34 LINK C ALA F 5 N DVA F 6 1555 1555 1.32 LINK C DVA F 6 N VAL F 7 1555 1555 1.33 LINK C VAL F 7 N DVA F 8 1555 1555 1.33 LINK C DVA F 8 N TRP F 9 1555 1555 1.33 LINK C TRP F 9 N DLE F 10 1555 1555 1.32 LINK C DLE F 10 N TRP F 11 1555 1555 1.34 LINK C TRP F 11 N DLE F 12 1555 1555 1.33 LINK C DLE F 12 N TRP F 13 1555 1555 1.33 LINK C TRP F 13 N DLE F 14 1555 1555 1.33 LINK C DLE F 14 N TRP F 15 1555 1555 1.33 LINK C TRP F 15 N ETA F 16 1555 1555 1.35 LINK O5 15P A1016 NA NA A1018 1555 1555 3.17 LINK O6 15P A1016 NA NA A1018 1555 1555 2.98 LINK O7 15P A1016 NA NA A1018 1555 1555 3.10 LINK O1 15P A1017 NA NA A1018 1555 1555 3.09 SITE 1 AC1 10 TRP A 15 ETA A 16 15P A1017 NA A1018 SITE 2 AC1 10 DLE B 4 DLE C 4 TRP D 15 ETA D 16 SITE 3 AC1 10 DLE E 14 TRP E 15 SITE 1 AC2 5 15P A1016 NA A1018 FVA B 1 TRP D 15 SITE 2 AC2 5 ETA D 16 SITE 1 AC3 3 15P A1016 15P A1017 TRP D 15 SITE 1 AC4 17 TRP A 9 DLE A 10 TRP A 11 TRP B 9 SITE 2 AC4 17 DLE B 10 TRP B 11 TRP C 9 TRP C 13 SITE 3 AC4 17 15P C1016 DLE D 10 TRP D 11 TRP D 15 SITE 4 AC4 17 TRP E 9 TRP E 13 DLE F 10 TRP F 11 SITE 5 AC4 17 TRP F 15 SITE 1 AC5 3 15P B1016 DVA C 8 TRP C 13 SITE 1 AC6 24 15P A1016 FVA B 1 GLY B 2 ALA B 3 SITE 2 AC6 24 DLE B 4 ALA B 5 DVA B 6 VAL B 7 SITE 3 AC6 24 DVA B 8 TRP B 9 DLE B 10 TRP B 11 SITE 4 AC6 24 DLE B 12 TRP B 13 DLE B 14 TRP B 15 SITE 5 AC6 24 ETA B 16 15P B1016 ALA C 5 TRP C 13 SITE 6 AC6 24 GLY D 2 ALA E 5 ALA F 3 DVA F 8 SITE 1 AC7 26 FVA A 1 GLY A 2 ALA A 3 DLE A 4 SITE 2 AC7 26 ALA A 5 DVA A 6 VAL A 7 DVA A 8 SITE 3 AC7 26 TRP A 9 DLE A 10 TRP A 11 DLE A 12 SITE 4 AC7 26 TRP A 13 DLE A 14 TRP A 15 ETA A 16 SITE 5 AC7 26 15P A1016 15P A1017 15P B1016 ALA C 5 SITE 6 AC7 26 ALA D 3 DVA D 8 ALA E 5 TRP E 13 SITE 7 AC7 26 GLY F 2 TRP F 11 SITE 1 AC8 23 ALA A 3 TRP A 11 15P A1016 DLE B 4 SITE 2 AC8 23 15P B1016 15P C1016 FVA D 1 GLY D 2 SITE 3 AC8 23 ALA D 3 DLE D 4 ALA D 5 DVA D 6 SITE 4 AC8 23 VAL D 7 DVA D 8 TRP D 9 DLE D 10 SITE 5 AC8 23 TRP D 11 DLE D 12 TRP D 13 DLE D 14 SITE 6 AC8 23 TRP D 15 ETA D 16 TRP F 11 SITE 1 AC9 23 GLY A 2 15P A1016 15P A1017 NA A1018 SITE 2 AC9 23 DLE B 12 TRP B 13 15P B1016 GLY C 2 SITE 3 AC9 23 ALA C 3 DLE C 4 ALA C 5 DVA C 6 SITE 4 AC9 23 VAL C 7 DVA C 8 TRP C 9 DLE C 10 SITE 5 AC9 23 TRP C 11 DLE C 12 TRP C 13 DLE C 14 SITE 6 AC9 23 TRP C 15 ETA C 16 TRP E 9 SITE 1 BC1 23 DLE A 4 15P A1016 ALA B 3 TRP B 11 SITE 2 BC1 23 15P B1016 TRP D 11 HOH E2001 HOH E2002 SITE 3 BC1 23 FVA F 1 ALA F 3 DLE F 4 ALA F 5 SITE 4 BC1 23 DVA F 6 VAL F 7 DVA F 8 TRP F 9 SITE 5 BC1 23 DLE F 10 TRP F 11 DLE F 12 TRP F 13 SITE 6 BC1 23 DLE F 14 TRP F 15 ETA F 16 SITE 1 BC2 22 DLE A 12 TRP A 13 GLY B 2 TRP B 11 SITE 2 BC2 22 15P B1016 TRP C 9 GLY E 2 ALA E 3 SITE 3 BC2 22 DLE E 4 ALA E 5 DVA E 6 VAL E 7 SITE 4 BC2 22 DVA E 8 TRP E 9 DLE E 10 TRP E 11 SITE 5 BC2 22 DLE E 12 TRP E 13 DLE E 14 TRP E 15 SITE 6 BC2 22 ETA E 16 HOH E2001 CRYST1 30.500 62.560 30.530 90.00 99.97 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.032787 0.000000 0.005764 0.00000 SCALE2 0.000000 0.015985 0.000000 0.00000 SCALE3 0.000000 0.000000 0.033257 0.00000 MTRIX1 1 0.059810 -0.031190 -0.997720 33.76385 1 MTRIX2 1 -0.150340 -0.988390 0.021890 -4.49545 1 MTRIX3 1 -0.986820 0.148690 -0.063810 16.96919 1 MTRIX1 2 -0.980830 0.152540 0.121250 -1.96999 1 MTRIX2 2 0.151470 0.988300 -0.018110 0.70732 1 MTRIX3 2 -0.122590 0.000610 -0.992460 21.14136 1 HETATM 1 C FVA A 1 4.506 12.759 18.233 1.00 18.07 C HETATM 2 N FVA A 1 2.936 14.520 17.602 1.00 17.27 N HETATM 3 O FVA A 1 3.674 11.847 17.908 1.00 16.46 O HETATM 4 CA AFVA A 1 4.019 14.196 18.528 0.70 16.85 C HETATM 5 CA BFVA A 1 4.069 14.191 18.468 0.30 16.15 C HETATM 6 CB AFVA A 1 3.480 14.352 19.969 0.70 18.65 C HETATM 7 CB BFVA A 1 3.784 14.419 19.984 0.30 16.60 C HETATM 8 CG1AFVA A 1 2.206 13.499 20.170 0.70 21.50 C HETATM 9 CG1BFVA A 1 3.335 15.852 20.256 0.30 12.20 C HETATM 10 CG2AFVA A 1 4.531 14.031 21.010 0.70 19.57 C HETATM 11 CG2BFVA A 1 2.772 13.401 20.536 0.30 18.42 C HETATM 12 O1 FVA A 1 3.663 16.665 17.343 1.00 18.31 O HETATM 13 CN FVA A 1 2.893 15.743 16.997 1.00 19.65 C